molmedgmp.com
MolMed S.p.A.MolMed S.p.A. is a medical biotechnology company focused on research, development and clinical validation of innovative therapies to treat cancer.
http://www.molmedgmp.com/
MolMed S.p.A. is a medical biotechnology company focused on research, development and clinical validation of innovative therapies to treat cancer.
http://www.molmedgmp.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
0.6 seconds
MOLMED S.P.A.
Via Ol●●●●●●na, 58
Mi●●no , 20132
IT
View this contact
Claudio Bordignon
Claudio Bordignon
Via Ol●●●●●●na, 58
Mi●●no , 20132
IT
View this contact
Register.it S.p.A.
Register.it S.p.A.
Via Mo●●●●●●ri s/n
Be●●mo , 24126
IT
View this contact
BUY YOUR DOMAIN
14
YEARS
0
MONTHS
6
DAYS
REGISTER.IT SPA
WHOIS : whois.register.it
REFERRED : http://we.register.it
PAGES IN
THIS WEBSITE
19
SSL
EXTERNAL LINKS
0
SITE IP
176.58.106.33
LOAD TIME
0.625 sec
SCORE
6.2
MolMed S.p.A. | molmedgmp.com Reviews
https://molmedgmp.com
MolMed S.p.A. is a medical biotechnology company focused on research, development and clinical validation of innovative therapies to treat cancer.
molmedgmp.com
MolMed S.p.A.
http://www.molmedgmp.com/node/38
Website is designed to be compliant to W3C ( World Wide Consortium. Reccomendations. The site is built to be platform indipendent to garantee an easy access to a vast majority of users, including those using assistive technologies. We are always improving our site's accessibility, please send any suggestion or remark to our contact address. Cell and Gene therapy. SpA Via Olgettina, 58 - 20132 Milano, Italy. Phone 39 0221277.1 - Fax 39 02 21277.325. Info@molmed.com - www.molmed.com.
MolMed S.p.A.
http://www.molmedgmp.com/node/70
S business strategy strongly relies on establishing strategic alliances with major biotech and pharmaceutical companies, in order to foster the development of its leading products through co-development, co-marketing or out-licensing partnerships. Intends to out-license some of its leading products for selected indications and territories:. NGR-hTNF vascular targeting agent. Offers out-licensing of a novel therapeutic gene ,. Aug 22, 2016. Aug 1, 2016. Jul 1, 2016. Subscribe to press releases. E-mail: bu...
MolMed S.p.A.
http://www.molmedgmp.com/node/41
Nov 10, 2015. Notice of ordinary shareholders' meeting. Aug 1, 2014. Notice of ordinary and extraordinary Shareholders' Meeting. May 14, 2014. Financial report at 31 march 2014 (in Italian). Annual financial report (English translation for convenience) 2015. Half-year financial report -English translation for convenience at. Interim financial report (English translation for convenience) at. Interim financial report (in Italian) at. Guidelines for the internal control system (in Italian). Jun 10, 2016.
MolMed S.p.A.
http://www.molmedgmp.com/node/2014
Online Investor kit delivers some useful tools. To request additional documents or information, please complete the Investor contact form. Relazione finanziaria annuale 2013 [3.88 MB]. Presentazione delle società Jefferies Conference NYC giugno 2014 (in inglese) [1.25 MB]. Annual financial report (English translation for convenience) 2013 [1.6 MB]. Company presentation Jefferies Conference NYC June 2014 [1.25 MB]. Investor Relations and Communication Director. Phone: 39 02 21277.1. Name and Surname *.
MolMed S.p.A.
http://www.molmedgmp.com/node/1866
The best treatment currently available for leukaemias and other haematological malignancies is the transplant of haematopoietic stem cells (HSCT) from healthy donors. However, fully compatible donors are available only for approximately 50% of patients. TK is an ex vivo cell therapy, enabling safe HSCT from partially compatible haplo-identical donors (e.g. mother, father, brothers or sisters), who are available for nearly all patients. Administration of TK therapy following HSCT promotes early and sustai...
TOTAL PAGES IN THIS WEBSITE
19
О журнале | Молекулярная медицина
Перейти к основному содержанию. Научно-практический журнал / ISSN 1728-2918. Молекулярная медицина - журнал освещает результаты научных исследований в таких областях, как исследование молекулярных и генетических основ этиологии и патогенеза социально значимых заболеваний с целью разработки новых методов диагностики и способов эффективной терапии заболеваний человека, в том числе на основе технологий ядерной медицины. Cогласно решению Президиума Высшей аттестационной комиссии (ВАК) журнал Молекулярная мед...
Nikolaus-Fiebiger-Zentrum für Molekulare Medizin
Lehrstuhl für Experimentelle Medizin I - Molekulare Pathogeneseforschung. Lehrstuhl für Experimentelle Medizin II - Molekulare Tumorforschung. Abteilung für Molekulare Immunologie. IZKF Nachwuchsgruppe II AG Paolo Ceppi. IZKF Nachwuchsgruppe III Beate Winner. AG Aline Bozec /Med III. AG Raymund Horch /Plastische und Handchirurgie. AG Gerhard Krönke /Med III. Tel: 49 (9131) 85-29100. Fax: 49 (9131) 85-26341. Routenplaner für die Anreise. Research Report 2012 (PDF, 23.2 MB).
"Institut für Molekulare Medizin"
53° 50' 17' N. 10° 42' 18' E. Welcome to the Website of the Institute of Molecular Medicine (IMM) at the University of Lübeck and the. University Hospital Schleswig-Holstein, Campus Lübeck. Willkomm,S., Deerberg,A., Heidemann,J., Flügge,F., Meine,J., Hu,R., Kretschmer-Kazemi Far,R., Restle, T. (2016) Recombinant hTRBP and hPACT Modulate hAgo2-Catalyzed siRNA-Mediated Target RNA Cleavage in Vitro. PLoS One, 11(1):e0146814. doi: 10.1371/journal.pone.0146814. Institut für Molekulare Medizin.
遺伝子機能応用学研究室
Biological and Pharmaceutical Bulletinに論文が受理されました. (FAP関連. Integrative Molecular Medicine. に論文が掲載されました. 自然免疫関連、国際共同研究. J Mol Cell Biol. Biological and Pharmaceutical Bulletin. Mol Ther Nucleic Acids. J Am Soc Nephrol. Proc Natl Acad Sci U S A. に論文 総説 が掲載されました (CFTR-itch関連). 2011/12/28] 甲斐教授 教員生活25周年および教授就任10周年記念 研究教育業績集. 862-0973 熊本市大江本町5-1 TEL/FAX 096-371-4407. Hirokai@gpo.( kumamoto-u.ac.jp). Tshuto@( mail.molmed730.org).
Faculty of Medicine - Department of Molecular Medicine and Biotechnology
Department of Molecular Medicine and Biotechnology. 385 51 651 197 (office). 385 51 651 226 (lab). 385 51 651 197. November 10-11, 2011 . Department of Molecular Medicine and Biotechnology. Design by otvorena.hr.
MolMed S.p.A.
Alliance for Regenerative Medicine. Luca Alberici, Ph.D.,. Professor Mohamad Mohty (EBMT President) at the 58th Annual Meeting of the American Society of Hematology (ASH). SpA is a medical biotechnology company focused on research, development and clinical validation of innovative therapies to treat cancer. Apr 17, 2018. 6th Annual Cell and Gene Therapy Investor Day 17 april NY. Apr 3, 2018. Tg2 Medicina33 Haploidentical transplantation and new cell therapies, interview with Fabio Ciceri. Feb 1, 2018.
Романтичні міста
Логин или эл. почта:. Rarr; Палац Сант-Еліа. Палац Сант-Еліа 16 століття в Палермо яскравий приклад архітектури бароко. Цей особняк має висоту більше 75 метрів і є одним з найрозкішніших будинків міста. Будівництво палацу за спеціальним проектом архітектора Ніколо Аніта, який був відомим королівським інженером, було закінчено в 1756 році. Після землетрусу в 1823 році палац Сант-Еліа сильно постраждав, після чого був зданий в оренду барону Чиотти. Періодично тут жили знатні сім'ї Сицилії. У 1756 році особ...
molmedicaltidbits.wordpress.com
Manbir Online ~ Medical Tidbits | Just another WordPress.com site
Manbir Online Medical Tidbits. Just another WordPress.com site. Eat and Cook Healthy. May 5, 2011. Manbir & Gurpreet. Eat and Cook Healthy. To lead a healthy and fit life we need to eat and cook healthy. Here are few tips which may be of help in keeping you fit and eat healthy food. Substitute whole milk with skimmed milk. Make curd and paneer (cheese) from skimmed milk. Instead of frying prefer baking, grilling, roasting and steaming of food. Use brown ( unpolished ) rice. Use whole wheat flour with bran.
Web Page Under Construction
This Site Is Under Construction and Coming Soon. This Domain Is Registered with Network Solutions.
